Skip to main content

Breadcrumb

  1. Home

Cardiovascular

Cardiovascular

The Cardiovascular Standing Committee  oversees the consensus based entity's portfolio of Cardiovascular measures, which includes measures for acute myocardial infarction, percutaneous coronary intervention, ischemic vascular disease, heart failure, hypertension, rhythm disorders, and valvular heart disease.

Measures

Project

Measures

CBE ID Title Sort descending Steward Submission Type E&M Cycle
0288 Fibrinolytic Therapy Received Within 30 Minutes of ED Arrival Centers for Medicare & Medicaid Services Maintenance Full Year 2016
0164 Fibrinolytic Therapy received within 30 minutes of hospital arrival Centers for Medicare & Medicaid Services Maintenance Full Year 2016
2764e Fixed-dose Combination of Hydralazine and Isosorbide Dinitrate Therapy for Self-identified Black or African American Patients with Heart Failure and LVEF <40% on ACEI or ARB and Beta-blocker Therapy National Minority Quality Forum Spring 2023
0078 Heart Failure (HF) : Assessment of Clinical Symptoms of Volume Overload (Excess) Physician Consortium for Performance Improvement Maintenance Full Year 2013
0082 Heart Failure (HF) : Patient Education Physician Consortium for Performance Improvement Maintenance Full Year 2010
0084 Heart Failure (HF) : Warfarin Therapy Patients with Atrial Fibrillation Physician Consortium for Performance Improvement Maintenance Full Year 2010
0085 Heart Failure (HF) : Weight Measurement Physician Consortium for Performance Improvement Maintenance Full Year 2010
0081e Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) American College of Cardiology Maintenance Spring 2019
0081 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) American College of Cardiology Maintenance Spring 2019
0083e Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) American College of Cardiology Maintenance Spring 2019
Final Reports

Media

Final Reports

Report name Cycle

Reports Coming Soon!

Events

Events

Upcoming Events

Events

Archived Events

Events

Materials

Materials

Materials

Material File Material Type Cycle
There are no materials that meet your filter criteria available for this project at this time. Content is being updated on a continual basis.